Surgical treatment of advanced colorectal cancer
Authors:
M. Levý; V. Visokai; L. Lipská; K. Veškrňa; J. Šimša
Authors‘ workplace:
Přednosta: doc. MUDr. Jaromír Šimša, Ph. D.
; Chirurgická klinika 1. LF UK a Thomayerovy nemocnice Praha
Published in:
Prakt. Lék. 2017; 97(1): 9-16
Category:
Reviews
Overview
Colorectal cancer is one of the most common malignant diseases in developed countries, its incidence is increasing. In the Czech Republic is incidence very high and it is, excluding all skin cancers, on the first place in all cancers. Advanced colorectal cancer, unfortunately, affects a considerable proportion of our population. Emerging opportunities of multimodality treatment significantly improve the prognosis of these patients. The only chance for long term survival is radical surgical resection. For locally advanced tumors is multiorgan resection indicated. In the case of metastatic disease, both liver and lungs, we must always consider the possibility of resection of these metastases. In case of synchronous metastases we can performe simultaneous resection or staged resection. Liver first approach is prefered recently. In the case of metastatic peritoneal dissemination we must consider cytoreductive surgery and HIPEC, although the resectability of such involvement is low.
When deciding on multiple organ resection, pelvic exenteration, resection of liver or lung metastases, cytoreductive surgery or HIPEC we consider overall assessment findings, all available tests and overall condition of the patient in a multidisciplinary team (MDT). All patients with advanced colorectal cancer should be discussed in these teams, even though it seems to be primarily inoperable.
Keywords:
advanced colorectal cancer – resection of metastases – cytoreductive surgery and HIPEC
Sources
1. Antoš F, Vítek P, Marx J, a kol. Cytoreduktivní chirurgie a hypertermická intraperitoneální peroperační chemoterapie (CRS + HIPEC) – patří už nyní do léčebných standardů? Klin Onkol 2016; 29(Suppl 2): 2S49.
2. Aoyagi T, Terracina KP, Raza A, et al. Current treatment options for colon cancer peritoneal carcinomatosis. World J Gastroenterol 2014; 20(35): 12493–12500.
3. Čapov I, Doležel J, Vlček P, a kol. Opakované plicní resekce v chirurgii plicních metastáz. Rozhl Chir 2013; 12: 694–698.
4. Dušek L, Mužík J, Kubásek M, a kol. Epidemiologie zhoubných nádorů v České republice [online]. Masarykova univerzita [2005] [cit. 2016-11-04]. Dostupný z: http://www.svod.cz. Verze 7.0 [2007].
5. Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer 2013. Available from: http://globocan.iarc.fr
6. Kala Z, Kysela P. Chirurgická resekční léčba jaterních metastáz kolorektálního karcinomu. Medicína po promoci 2012; 13(5–6): 53–59.
7. Levý M, Mráček M, Jirsová A, a kol. Možnosti léčby synchronních jaterních metastáz kolorektálního karcinomu. Lékařské listy 4/2014; 15–17.
8. Mráček M, Strnad R. Chirurgická léčba jaterních metastáz kolorektálního karcinomu. Postgraduální medicína 2015; 17(2): 130–137.
9. Ryska M, Pantoflíček J, Dušek L. Léčba jaterních metastáz kolorektálního původu v České republice: současný celostátní survey. Rozhl Chir 2010; 89: 100–108.
10. Šimša J, Visokai V, Lipská L, Levý M. Pánevní exenterace v léčbě pokročilých nádorů malé pánve. Rozhl Chir 2014; 93(1): 34–37.
11. Visokai V, Lipska L, Bergmann P, et al. Multiorgan resections for advanced colorectal cancer. Anticancer Res 2006; 26(4B): 3183–3186.
Labels
General practitioner for children and adolescents General practitioner for adultsArticle was published in
General Practitioner
2017 Issue 1
Most read in this issue
- Paracetamol poisoning
- Risk factors of falls in hospitalized patients
- Multiple chemical sensitivity
- Duties of attending physician in assessing the health status for the purposes of disability, social security benefits and employment